Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)
J. Barker, M. Hoffmann, G. Wozel, J.-P. Ortonne, H. Zheng, H. van Hoogstraten, K. ReichVolume:
165
Year:
2011
Language:
english
Pages:
9
DOI:
10.1111/j.1365-2133.2011.10615.x
File:
PDF, 346 KB
english, 2011